Kinesia is a compact, clinical device for objectively quantifying motor symptoms of movement disorders such as
Parkinson’s disease and essential tremor. Kinesia is worn on the finger and wrist of the patient while symptom information is wirelessly transmitted to a nearby computer for display, analysis, automated symptom severity scoring, report generation and storage. Kinesia can be used with Parkinson’s disease patients to monitor the kinematics of motor symptoms such as tremor and bradykinesia. A 0 to 4 severity score is provided for tremor assessment tasks as well as hand movements such as hand opening/closing, finger tapping and pronation/supination. The tremor severity scores correlate to the current gold standard, the Unified Parkinson’s Disease Rating Scale. This information can be useful for monitoring Parkinson’s disease symptom severity in clinical research applications, providing the opportunity to track symptom fluctuations throughout the course of a day as well as symptom response to treatment interventions such as medication or deep brain stimulation surgery.
The device can also be a useful research tool for many types of movement disorder motion analysis as well as evaluating treatment interventions such as deep brain stimulation. Kinesia can be used in pharmaceutical trials in which new drugs are being developed and evaluated to treat movement disorders such as Parkinson’s disease. The Kinesia system provides a standardized platform in which the motor effects of drugs can be consistently and objectively quantified instead of relying on more subjective methods such as rating scales and patient diaries.